Case Report
BibTex RIS Cite
Year 2023, Volume: 5 Issue: 1, 76 - 79, 20.01.2023
https://doi.org/10.38053/acmj.1206669

Abstract

References

  • Wagenlehner FM, Lichtenstern C, Rolfes C, et al. Diagnosis and management for urosepsis. Int J Urol 2013; 20: 963–70
  • Sarikaya K, Senocak C, Ciftcit M, et al. The effectiveness of percutaneous nephrolithotomy for the treatment of large impacted upper ureteral stones. Anatolian Curr Med J 2021;3: 165–70.
  • Ryan J, O’Neill E, McLornan L, Urosepsis and the urologist. Curr Urol 2021; 15: 39-44.
  • Nortina Shahrizaila, Helmar C Lehmann, Satoshi Kuwabara. Guillain-Barré syndrome. Lancet 2021; 397: 1214-28.
  • Van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barré syndrome. Neurology 2013; 80: 1650–54.
  • Hao Y, Wang W, Jacobs BC, et al. Antecedent infections in Guillain-Barré syndrome: a single-center, prospective study. Ann Clin Transl Neurol 2019; 6: 2510-17
  • Leonhard SE, Mandarakas MR, Francisco A, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol 2019; 15: 671-83.
  • Fischer A, Avila J. Guillain-Barré syndrome following an extended-spectrum beta-lactamase Escherichia coli urinary tract infection: a case report J Cureus 2021; 13: e19673.
  • Kono Y, Nishitarumizu K, Higashi T, Funakoshi K, Odaka. Rapidly progressive Guillain-Barré syndrome following Escherichia coli infection. M Intern Med 2007; 46: 589-91.
  • Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barr and Fisher syndromes. Lancet Infect Dis 2001; 1: 29-37.

A rare complication of Escherichia coli induced urosepsis; is Guillain-Barre syndrome

Year 2023, Volume: 5 Issue: 1, 76 - 79, 20.01.2023
https://doi.org/10.38053/acmj.1206669

Abstract

Guillain Barre syndrome (GBS) is the most common neurological cause of acute flaccid paralysis worldwide. Early diagnosis and treatment of GBS are vital due to possible deadly consequences. Awareness of the silent neurological symptoms in patients preparing for upcoming surgery may have critically crucial for a urologist. Developing GBS after relieving urosepsis is rarely addressed in the literature. Therefore, this report presents an infrequent complication of Escherichia coli (E. coli)-induced urosepsis, GBS. A 47-year-old female patient was admitted to the emergency department in a septic state. During the intensive care unit management with the preliminary diagnosis of sepsis-related hypovolemic shock, a nephrostomy catheter was placed in an obstructed left kidney due to impacted upper ureteral calculus with 1.5 cm in size. Following the improvement of the patient’s condition in intensive care unit with proper management, the patient was transferred to the urology ward for definitive treatment. During the follow-up, however, the patient showed some neurological signs and symptoms considering GBS. An obtained cerebral spinal fluid analysis revealed an albumin-cytologic dissociation and examining the patient underpinned the diagnosis. The patient was treated with intravenous immunoglobulin for five days, according to the guidlines. After the treatment, the patient’s condition improved rapidly following two weeks. The left obstructed ureteral stones were removed with ureteroscopy. A stone-free status was achieved the following month. GBS is the most common cause of acute flaccid paralysis worldwide, and proper management is essential due to poor prognosis. GBS after a uroseptic condition is sporadic, but any surgery on patients who experience active GBS would bode for severe consequences, so awareness of the silent neurological symptoms in patients prepared for upcoming surgery is vital for a urologist. We aimed to remind with this report of the possibility of GBS for a patient who expresses neurological symptoms following a septic state. 

References

  • Wagenlehner FM, Lichtenstern C, Rolfes C, et al. Diagnosis and management for urosepsis. Int J Urol 2013; 20: 963–70
  • Sarikaya K, Senocak C, Ciftcit M, et al. The effectiveness of percutaneous nephrolithotomy for the treatment of large impacted upper ureteral stones. Anatolian Curr Med J 2021;3: 165–70.
  • Ryan J, O’Neill E, McLornan L, Urosepsis and the urologist. Curr Urol 2021; 15: 39-44.
  • Nortina Shahrizaila, Helmar C Lehmann, Satoshi Kuwabara. Guillain-Barré syndrome. Lancet 2021; 397: 1214-28.
  • Van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barré syndrome. Neurology 2013; 80: 1650–54.
  • Hao Y, Wang W, Jacobs BC, et al. Antecedent infections in Guillain-Barré syndrome: a single-center, prospective study. Ann Clin Transl Neurol 2019; 6: 2510-17
  • Leonhard SE, Mandarakas MR, Francisco A, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol 2019; 15: 671-83.
  • Fischer A, Avila J. Guillain-Barré syndrome following an extended-spectrum beta-lactamase Escherichia coli urinary tract infection: a case report J Cureus 2021; 13: e19673.
  • Kono Y, Nishitarumizu K, Higashi T, Funakoshi K, Odaka. Rapidly progressive Guillain-Barré syndrome following Escherichia coli infection. M Intern Med 2007; 46: 589-91.
  • Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barr and Fisher syndromes. Lancet Infect Dis 2001; 1: 29-37.
There are 10 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Case Report
Authors

Timuçin Şipal 0000-0003-3992-2013

Melıha Turksever 0000-0002-8125-9561

Hatice Tezcan 0000-0002-3424-4332

Ercan Yuvanç 0000-0002-5822-6972

Early Pub Date January 17, 2023
Publication Date January 20, 2023
Published in Issue Year 2023 Volume: 5 Issue: 1

Cite

AMA Şipal T, Turksever M, Tezcan H, Yuvanç E. A rare complication of Escherichia coli induced urosepsis; is Guillain-Barre syndrome. Anatolian Curr Med J / ACMJ / acmj. January 2023;5(1):76-79. doi:10.38053/acmj.1206669

TR DİZİN ULAKBİM and International Indexes (1b)

Interuniversity Board (UAK) Equivalency:  Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/3449/file/4924/show

Journal Indexes and Platforms: 

TR Dizin ULAKBİM, Google Scholar, Crossref, Worldcat (OCLC), DRJI, EuroPub, OpenAIRE, Turkiye Citation Index, Turk Medline, ROAD, ICI World of Journal's, Index Copernicus, ASOS Index, General Impact Factor, Scilit.


The indexes of the journal's are;

18596


asos-index.png

f9ab67f.png

WorldCat_Logo_H_Color.png

      logo-large-explore.png

images?q=tbn:ANd9GcQgDnBwx0yUPRKuetgIurtELxYERFv20CPAUcPe4jYrrJiwXzac8rGXlzd57gl8iikb1Tk&usqp=CAU

index_copernicus.jpg


84039476_619085835534619_7808805634291269632_n.jpg





The platforms of the journal's are;

COPE.jpg

images?q=tbn:ANd9GcTbq2FM8NTdXECzlOUCeKQ1dvrISFL-LhxhC7zy1ZQeJk-GGKSx2XkWQvrsHxcfhtfHWxM&usqp=CAUicmje_1_orig.png

cc.logo.large.png

ncbi.png

ORCID_logo.pngimages?q=tbn:ANd9GcQlwX77nfpy3Bu9mpMBZa0miWT2sRt2zjAPJKg2V69ODTrjZM1nT1BbhWzTVPsTNKJMZzQ&usqp=CAU


images?q=tbn:ANd9GcTaWSousoprPWGwE-qxwxGH2y0ByZ_zdLMN-Oq93MsZpBVFOTfxi9uXV7tdr39qvyE-U0I&usqp=CAU






The
 
indexes/platforms of the journal are;

TR Dizin Ulakbim, Crossref (DOI), Google Scholar, EuroPub, Directory of Research Journal İndexing (DRJI), Worldcat (OCLC), OpenAIRE, ASOS Index, ROAD, Turkiye Citation Index, ICI World of Journal's, Index Copernicus, Turk Medline, General Impact Factor, Scilit 


EBSCO, DOAJ, OAJI is under evaluation.

Journal articles are evaluated as "Double-Blind Peer Review"